Cargando…
Targeted Axillary Dissection with (125)I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
BACKGROUND: Targeted axillary dissection (TAD), with marking of the metastatic lymph node before neoadjuvant chemotherapy (NACT), is increasingly used for breast cancer axillary staging. In the case of axillary pathological complete response (ax-pCR), axillary lymph node clearance can be omitted. Se...
Autores principales: | Munck, Frederikke, Andersen, Inge S., Vejborg, Ilse, Gerlach, Maria K., Lanng, Charlotte, Kroman, Niels T., Tvedskov, Tove H. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250439/ https://www.ncbi.nlm.nih.gov/pubmed/37062781 http://dx.doi.org/10.1245/s10434-023-13432-4 |
Ejemplares similares
-
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study
por: Munck, Frederikke, et al.
Publicado: (2023) -
Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
por: Martelli, Gabriele, et al.
Publicado: (2010) -
Same‐day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer
por: Tamminen, Anselm, et al.
Publicado: (2022) -
Immediate Lymphatic Reconstruction during Axillary Node Dissection for Breast Cancer: A Systematic Review and Meta-analysis
por: Hill, W. K. Fraser, et al.
Publicado: (2022) -
Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019)